|
During the 1st month of follow-up:
| | | | | |
|
Patients reporting WA/STD (n, %)
|
2,980
|
88.6
|
2,591
|
77.1
|
<.001
|
|
Monthly hours lost due to WA/STD (mean, SD)
|
78.7
|
63.5
|
22.4
|
30.3
|
<.001
|
|
Indirect costs associated with WA/STD (mean, SD)
|
$1,744
|
$1,293
|
$624
|
$785
|
<.001
|
|
Patients with ≥ 1 year of follow-up (n, %)
|
2,030
|
60.4
|
2,249
|
66.9
| |
|
During the 1st year of follow-up:
| | | | | |
|
Patients reporting WA/STD (n, %)
|
1,917
|
94.4
|
2,093
|
93.1
|
0.07
|
|
Monthly hours lost due to WA/STD (mean, SD)
|
35.0
|
29.3
|
21.4
|
14.1
|
<.001
|
|
Indirect costs associated with WA/STD (mean, SD)
|
$847
|
$572
|
$610
|
$374
|
<.001
|
|
Patients with ≥ 2 years of follow-up (n, %)
|
1,184
|
35.2
|
1,364
|
40.6
| |
|
During the 2nd year of follow-up:
| | | | | |
|
Patients reporting WA/STD (n, %)
|
1,088
|
91.9
|
1,294
|
94.9
|
0.002
|
|
Monthly hours lost due to WA/STD (mean, SD)
|
22.2
|
18.0
|
21.2
|
13.7
|
0.12
|
|
Indirect costs associated with WA/STD (mean, SD)
|
$590
|
$389
|
$590
|
$337
|
0.99
|
|
Patients with ≥ 3 years of follow-up (n, %)
|
622
|
18.5
|
759
|
22.6
| |
|
During the 3rd year of follow-up:
| | | | | |
|
Patients reporting WA/STD (n, %)
|
581
|
93.4
|
723
|
95.3
|
0.14
|
|
Monthly hours lost due to WA/STD (mean, SD)
|
21.3
|
16.2
|
20.7
|
12.9
|
0.44
|
|
Indirect costs associated with WA/STD (mean, SD)
|
$561
|
$359
|
$568
|
$305
|
0.68
|
